Gilead Sciences (Mexico) Analysis
| GILD Stock | MXN 1,892 79.51 4.39% |
Gilead Sciences is undervalued with Real Value of 2098.89 and Hype Value of 1892.4. The main objective of Gilead Sciences stock analysis is to determine its intrinsic value, which is an estimate of what Gilead Sciences is worth, separate from its market price. There are two main types of Gilead Sciences' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Gilead Sciences' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Gilead Sciences' stock to identify patterns and trends that may indicate its future price movements.
The Gilead Sciences stock is traded in Mexico on Mexican Exchange, with the market opening at 08:30:00 and closing at 15:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Mexico. Gilead Stock trading window is adjusted to America/Mexico City timezone.
Gilead |
Gilead Stock Analysis Notes
About 84.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.7. Gilead Sciences recorded earning per share (EPS) of 68.39. The entity last dividend was issued on the 14th of March 2023. The firm had 2:1 split on the 28th of January 2013. Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. The company was founded in 1987 and is headquartered in Foster City, California. GILEAD SCIENCES operates under Drug Manufacturers - Major classification in Mexico and is traded on Mexico Stock Exchange. It employs 11000 people. To learn more about Gilead Sciences call Daniel ODay at 650 574 3000 or check out https://www.gilead.com.Gilead Sciences Investment Alerts
| Gilead Sciences has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Over 84.0% of the company shares are owned by institutional investors |
Gilead Market Capitalization
The company currently falls under 'Mega-Cap' category with a current market capitalization of 2.01 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Gilead Sciences's market, we take the total number of its shares issued and multiply it by Gilead Sciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Gilead Profitablity
Gilead Sciences' profitability indicators refer to fundamental financial ratios that showcase Gilead Sciences' ability to generate income relative to its revenue or operating costs. If, let's say, Gilead Sciences is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Gilead Sciences' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Gilead Sciences' profitability requires more research than a typical breakdown of Gilead Sciences' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.17 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.4 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.4. Technical Drivers
As of the 1st of December, Gilead Sciences retains the Downside Deviation of 3.25, market risk adjusted performance of 2.1, and Risk Adjusted Performance of 0.1649. Gilead Sciences technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Gilead Sciences Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Gilead Sciences middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Gilead Sciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Gilead Sciences Predictive Daily Indicators
Gilead Sciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Gilead Sciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.04 | |||
| Day Median Price | 1892.4 | |||
| Day Typical Price | 1892.4 | |||
| Price Action Indicator | 39.75 | |||
| Period Momentum Indicator | 79.51 | |||
| Relative Strength Index | 97.14 |
Gilead Sciences Forecast Models
Gilead Sciences' time-series forecasting models are one of many Gilead Sciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Gilead Sciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Gilead Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Gilead Sciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Gilead shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Gilead Sciences. By using and applying Gilead Stock analysis, traders can create a robust methodology for identifying Gilead entry and exit points for their positions.
Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. The company was founded in 1987 and is headquartered in Foster City, California. GILEAD SCIENCES operates under Drug Manufacturers - Major classification in Mexico and is traded on Mexico Stock Exchange. It employs 11000 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Gilead Sciences to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Additional Tools for Gilead Stock Analysis
When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.